Springworks Therapeutics Inc 's ability to collect accounts receivable sequentially worsen to 6.1, pointing to a challenging and on top of that deteriorating business climate for the Biotechnology & Pharmaceuticals industry. Springworks Therapeutics Inc 's Accounts Receivable average collection period in the Mar 31 2025 quarter, has increased to 60 days, from 57 days, in the Dec 31 2024 quarter.

If we take a look into Healthcare sector 291 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2326, from overall ranking in the fourth quarter 2024 at 2566.

What is Receivable Turnover Ratio?
What is Springworks Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

SWTX Receivables Turnover Ratio	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter
Y / Y Receivable Change	159.82 %	679.73 %	-	-	-
Y / Y Revenue Change	133.68 %	1029.96 %	-	-	-
Receivable Turnover Ratio (TTM)	6.1	6.43	6.87	7.5	4.93
SWTX's Total Ranking	# 2326	# 2566	# 2102	#	#
Accounts Receivable average collection period days	60	57	53	49	74
Seq. Receivable Change	-12.74 %	40.23 %	34.56 %	57.8 %	161.87 %
Seq. Revenue Change	-20.25 %	24.84 %	-17.46 %	184.36 %	285.64 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 32
Healthcare Sector	# 292
Overall Market	# 2326

Receivable Turnover Ratio Statistics
High	Average	Low
6.87	6.46	6.1
(Sep 30 2024)		(Mar 31 2025)

SWTX Company Profile • Back to SWTX Efficiency Comparisons • Compare SWTX Receivables Turnover Ratio to its Competitors

Financial Statements
Springworks Therapeutics Inc 's Accounts Receivable	$ 40 Millions	Visit SWTX's Balance sheet
Springworks Therapeutics Inc 's Sales TTM	$ 220 Millions	Visit SWTX's Income Statement
Sources of SWTX's Revenues		Visit SWTX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
SWTX's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
SWTX's Growth Rates	SWTX's Roa	SWTX's Inventory Turnover Ratio	SWTX's Dividend Comparisons
SWTX's Profitability Ratios	SWTX's Roi	SWTX's Asset Turnover Ratio	SWTX's Dividend Growth
SWTX's Valuation Ratios	SWTX's Roe	SWTX's Financial Strength Ratios	SWTX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2025	Receivable at quarter ending Mar 31 2025
Mannkind Corporation	14.48	$ 297.595 Millions	$ 20.559 Millions
Icu Medical Inc	14.25	$ 2,419.911 Millions	$ 169.876 Millions
Inmed Pharmaceuticals Inc	14.25	$ 4.515 Millions	$ 0.317 Millions
Co diagnostics Inc	14.01	$ 3.498 Millions	$ 0.250 Millions
Biofrontera Inc	13.45	$ 59.599 Millions	$ 4.431 Millions
China Pharma Holdings Inc	13.28	$ 4.295 Millions	$ 0.323 Millions
Newamsterdam Pharma Company N v	13.25	$ 47.140 Millions	$ 3.559 Millions
Grail Inc	13.17	$ 130.711 Millions	$ 9.925 Millions
Rosecliff Acquisition Corp I	13.04	$ 29.581 Millions	$ 2.268 Millions
Quipt Home Medical Corp	13.03	$ 425.431 Millions	$ 32.657 Millions
Day One Biopharmaceuticals Inc	13.02	$ 161.922 Millions	$ 12.440 Millions
Ptc Therapeutics inc	12.99	$ 1,772.758 Millions	$ 136.420 Millions
Voyager Therapeutics Inc	12.89	$ 66.958 Millions	$ 5.196 Millions
Qhslab Inc	12.70	$ 2.289 Millions	$ 0.180 Millions
Vireo Growth Inc.	12.65	$ 99.797 Millions	$ 7.887 Millions
Nrc Health	12.64	$ 141.298 Millions	$ 11.177 Millions
Sangamo Therapeutics Inc	12.57	$ 63.756 Millions	$ 5.071 Millions
Longeveron Inc	12.52	$ 2.225 Millions	$ 0.178 Millions
Bellevue Life Sciences Acquisition Corp	12.30	$ 3.381 Millions	$ 0.275 Millions
Dyadic International Inc	12.07	$ 3.554 Millions	$ 0.294 Millions
Protalix Biotherapeutics inc	12.01	$ 59.764 Millions	$ 4.976 Millions
Corcept Therapeutics Inc	11.95	$ 685.446 Millions	$ 57.337 Millions
Chemed Corporation	11.87	$ 2,488.997 Millions	$ 209.620 Millions
Teladoc Health Inc	11.64	$ 2,552.812 Millions	$ 219.394 Millions
Option Care Health Inc	11.63	$ 5,185.674 Millions	$ 445.908 Millions
Integrated Biopharma Inc	11.63	$ 53.377 Millions	$ 4.590 Millions
Ensysce Biosciences Inc	11.56	$ 6.224 Millions	$ 0.538 Millions
Kyntra Bio Inc	11.41	$ 102.848 Millions	$ 9.018 Millions
Zomedica Corp	11.30	$ 27.377 Millions	$ 2.422 Millions
Lifeloc Technologies Inc	11.18	$ 8.662 Millions	$ 0.775 Millions

Date modified: 2026-09-02T08:18:52+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.